Cell Death and Disease,
Journal Year:
2024,
Volume and Issue:
15(9)
Published: Sept. 6, 2024
Studies
have
indicated
that
RAB17
expression
levels
are
associated
with
tumor
malignancy,
and
is
more
highly
expressed
in
endometrial
cancer
(EC)
tissues
than
peritumoral
tissues.
However,
the
roles
potential
mechanisms
of
EC
remain
undefined.
The
present
study
confirmed
facilitates
progression
by
suppressing
cellular
ferroptosis-like
alterations.
Mechanistically,
attenuated
ferroptosis
cells
inhibiting
transferrin
receptor
(TFRC)
protein
a
ubiquitin
proteasome-dependent
manner.
Because
blood-deprived
poor
energy
supply,
relationship
between
hypoglycemia
was
investigated.
increased
incubated
low-glucose
medium.
Moreover,
medium
limited
cell
promoted
through
RAB17-TFRC
axis.
vitro
results
were
corroborated
vivo
studies
clinical
data.
Overall,
revealed
promotes
survival
during
glucose
deprivation
onset
TFRC-dependent
ferroptosis.
Small,
Journal Year:
2023,
Volume and Issue:
19(37)
Published: May 24, 2023
Canonical
phototherapeutics
have
several
limitations,
including
a
lack
of
tumor
selectivity,
nondiscriminatory
phototoxicity,
and
hypoxia
aggravation.
The
microenvironment
(TME)
is
characterized
by
hypoxia,
acidic
pH,
high
levels
H2
O2
,
GSH,
proteases.
To
overcome
the
shortcomings
canonical
phototherapy
achieve
optimal
theranostic
effects
with
minimal
side
effects,
unique
TME
characteristics
are
employed
in
development
phototherapeutic
nanomedicines.
In
this
review,
effectiveness
three
strategies
for
developing
advanced
based
on
various
examined.
first
strategy
involves
targeted
delivery
to
tumors
assistance
TME-induced
nanoparticle
disassembly
or
surface
modification.
second
near-infrared
absorption
increase-induced
activation
triggered
factors.
third
enhancing
therapeutic
efficacy
ameliorating
TME.
functionalities,
working
principles,
significance
applications
highlighted.
Finally,
possible
challenges
future
perspectives
further
discussed.
Molecular Therapy — Nucleic Acids,
Journal Year:
2024,
Volume and Issue:
35(2), P. 102155 - 102155
Published: Feb. 16, 2024
Endometrial
cancer
(EC),
the
second
most
common
malignancy
in
female
reproductive
system,
has
garnered
increasing
attention
for
its
genomic
heterogeneity,
but
understanding
of
metabolic
characteristics
is
still
poor.
We
explored
dysfunctions
EC
through
a
comprehensive
multi-omics
analysis
(RNA-seq
datasets
from
The
Cancer
Genome
Atlas
[TCGA],
Cell
Line
Encyclopedia
[CCLE],
and
GEO
datasets;
Clinical
Proteomic
Tumor
Analysis
Consortium
[CPTAC]
proteomics;
CCLE
metabolomics)
to
develop
useful
molecular
targets
precision
therapy.
Unsupervised
consensus
clustering
was
performed
categorize
patients
into
three
metabolism-pathway-based
subgroups
(MPSs).
These
MPS
had
distinct
clinical
prognoses,
transcriptomic
alterations,
immune
microenvironment
landscape,
unique
patterns
chemotherapy
sensitivity.
Moreover,
MPS2
subgroup
better
response
immunotherapy.
Finally,
machine
learning
algorithms
(LASSO,
random
forest,
stepwise
multivariate
Cox
regression)
were
used
developing
prognostic
metagene
signature
based
on
molecules.
Thus,
13-hub
gene-based
classifier
constructed
predict
patients'
subtypes,
offering
more
accessible
practical
approach.
This
metabolism-based
classification
system
can
enhance
predictions
guide
strategies
immunotherapy
metabolism-targeted
therapy
EC.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Feb. 27, 2024
Abstract
Background
Mitochondrial
alterations,
often
dependent
on
unbalanced
mitochondrial
dynamics,
feature
in
the
pathobiology
of
human
cancers,
including
multiple
myeloma
(MM).
Flavanones
are
natural
flavonoids
endowed
with
targeting
activities.
Herein,
we
investigated
capability
Hesperetin
(Hes)
and
Naringenin
(Nar),
two
aglycones
Hesperidin
Naringin
flavanone
glycosides,
to
selectively
target
Drp1,
a
pivotal
regulator
prompting
anti-MM
activity.
Methods
Molecular
docking
analyses
were
performed
crystallographic
structure
Dynamin-1-like
protein
(Drp1),
using
Hes
Nar
molecular
structures.
Cell
viability
apoptosis
assessed
MM
cell
lines,
or
co-culture
systems
primary
bone
marrow
stromal
cells,
Titer
Glo
Annexin
V-7AAD
staining,
respectively;
clonogenicity
was
determined
methylcellulose
colony
assays.
Transcriptomic
carried
out
Ion
AmpliSeq™
platform;
mRNA
expression
levels
by
quantitative
RT-PCR
western
blotting,
respectively.
architecture
transmission
electron
microscopy.
Real
time
measurement
oxygen
consumption
high
resolution
respirometry
living
cells.
In
vivo
anti-tumor
activity
evaluated
NOD-SCID
mice
subcutaneously
engrafted
Results
found
accommodate
within
GTPase
binding
site
inhibit
Drp1
activity,
leading
hyperfused
mitochondria
reduced
OXPHOS.
vitro,
viability,
even
presence
patient-derived
triggering
ER
stress
apoptosis.
Interestingly,
rewired
metabolism
through
down-regulation
master
transcriptional
activators
(SREBF-1,
c-MYC)
lipogenesis
genes.
An
extract
Tacle,
Citrus
variety
rich
Naringin,
capable
recapitulate
phenotypic
perturbations
each
flavanone,
vivo.
Conclusion
proliferation,
rewire
induce
cells
via
antagonism
fission
driver
Drp1.
These
results
provide
framework
for
development
therapeutics
aberrant
dependencies.
Biologics,
Journal Year:
2024,
Volume and Issue:
Volume 18, P. 79 - 93
Published: March 1, 2024
Abstract:
Endometrial
cancer
(EC)
has
a
high
epidemiological
impact
with
incidence
and
mortality
rising
worldwide.
In
recent
years,
the
integration
of
pathologic
molecular
classification
provided
relevant
information
to
understand
heterogeneity
in
biology
EC,
which
led
evolution
management
patients.
Currently,
therapeutic
breakthroughs
have
been
made
advanced
EC
improve
oncologic
outcomes,
efforts
include
patient
reported
outcomes.
Precision
personalized
medicine
are
under
way
exploring
different
combination
approaches
target
cross-talk
pathways,
cell
microenvironment,
metabolic
vulnerabilities
drug
delivery.
Yet,
collaborative
needed
face
challenges
practice
by
refining
selection,
ideal
biomarker
identification,
de-escalation
therapies
according
emerging
genomic
features
EC.
Keywords:
endometrial
cancer,
targeted
therapy,
targets,
precision
Current Oncology,
Journal Year:
2025,
Volume and Issue:
32(2), P. 106 - 106
Published: Feb. 13, 2025
Diabetes
and
Cancer
are
the
most
complex
chronic
diseases,
accounting
for
significant
global
mortality
morbidity.
The
association
between
Type
2
DM
(T2DM)
endometrial
cancer
(EC)
is
multifaced,
sharing
numerous
risk
factors,
including
insulin
resistance,
obesity,
hypoxia,
oxidative
stress.
Hypoxia
plays
a
vital
role
in
T2DM
pathogenesis
by
altering
level
pancreatic
β-cell
failure
through
an
imbalance
antioxidant
enzymes
cellular
levels,
while
inflammation
contributes
to
EC
malignancy.
HIF-1α
potent
transcription
factor
involved
modulating
responses
hypoxia
within
disease
environment.
Targeting
signaling
cascade,
major
metabolic
regulator
may
contribute
advanced
therapeutic
advances.
This
review
focuses
on
EC,
especially
focusing
HIF
pathways.
These
intersect
with
key
pathways
pathology,
such
as
signaling,
PI3K/AKT,
mTOR
pathway,
MUC1/HIF-1α
hormonal
imbalance.
Understanding
this
relationship
paves
way
future
researchers
develop
HIF-1α-targeted
therapies
that
could
lead
novel
combination
treat
these
comorbid
conditions.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3322 - 3322
Published: April 2, 2025
Endometrial
cancer
(EC)
is
a
complex
gynecologic
malignancy
that
requires
deeper
understanding
of
its
molecular
basis
to
improve
therapeutic
strategies.
In
this
study,
we
investigated
the
role
fatty
acid
(FA)
reprogramming
in
progression
EC.
We
analyzed
FA
profiles
identify
stage-specific
changes
and
gene
expression
key
enzymes
involved
synthesis,
desaturation,
elongation,
transport,
oxidation
at
different
stages
Our
results
show
EC
tissues
have
lower
levels
saturated
branched-chain
FA,
higher
very
long-chain
n-3
polyunsaturated
(PUFA),
monounsaturated
with
exception
myristoleic
acid.
The
differences
n-6
PUFA
were
inconsistent.
Gene
analysis
revealed
upregulation
controlling
de
novo
including
ACACA,
FASN,
SCD1,
ELOVL1.
contrast,
genes
related
transport
cell
β-oxidation
was
downregulated.
some
metabolism
upregulated,
while
others
These
demonstrate
lipid
suggest
potential
targets
for
novel
interventions
Journal of Medical Internet Research,
Journal Year:
2025,
Volume and Issue:
27, P. e66530 - e66530
Published: April 18, 2025
Background
Endometrial
cancer
is
one
of
the
most
common
gynecological
tumors,
and
early
screening
diagnosis
are
crucial
for
its
treatment.
Research
on
application
artificial
intelligence
(AI)
in
endometrial
increasing,
but
there
currently
no
comprehensive
meta-analysis
to
evaluate
diagnostic
accuracy
AI
cancer.
Objective
This
paper
presents
a
systematic
review
AI-based
screening,
which
needed
clarify
provide
evidence
technology
Methods
A
search
was
conducted
across
PubMed,
Embase,
Cochrane
Library,
Web
Science,
Scopus
databases
include
studies
published
English,
evaluated
performance
screening.
total
2
independent
reviewers
screened
titles
abstracts,
quality
selected
assessed
using
Quality
Assessment
Diagnostic
Accuracy
Studies—2
(QUADAS-2)
tool.
The
certainty
test
Grading
Recommendations
Assessment,
Development,
Evaluation
(GRADE)
system.
Results
13
were
included,
hierarchical
summary
receiver
operating
characteristic
model
used
showed
that
overall
sensitivity
86%
(95%
CI
79%-90%)
specificity
92%
87%-95%).
Subgroup
analysis
revealed
similar
results
type,
study
region,
publication
year,
low.
Conclusions
can
effectively
detect
patients
with
cancer,
large-scale
population
future
further
Trial
Registration
PROSPERO
CRD42024519835;
https://www.crd.york.ac.uk/PROSPERO/view/CRD42024519835
Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
15(9), P. 2627 - 2645
Published: Jan. 1, 2024
The
incidence
and
mortality
of
gynecological
tumors
are
progressively
increasing
due
to
factors
such
as
obesity,
viral
infection,
unhealthy
habits,
well
social
economic
pressures.Consequently,
it
has
emerged
a
significant
threat
women's
health.Numerous
studies
have
revealed
the
remarkable
metabolic
activity
tumor
cells
in
glycolysis
its
ability
influence
malignant
biological
behavior
through
specific
mechanisms.Therefore,
is
crucial
for
patients
gynecologists
comprehend
role
glycolytic
proteins,
regulatory
molecules,
signaling
pathways
tumorigenesis,
progression,
treatment.This
article
aims
review
correlation
between
abnormal
glucose
metabolism
gynecologic
including
cervical
cancer
(CC),
endometrial
carcinoma
(EC),
ovarian
(OC).The
findings
from
this
research
will
provide
valuable
scientific
insights
early
screening,
timely
diagnosis
treatment
interventions
while
also
aiding
prevention
recurrence
among
individuals
with
tumors.
BMC Cancer,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: May 8, 2024
Glycometabolism
and
lipid
metabolism
are
critical
in
cancer
metabolic
reprogramming.
The
primary
aim
of
this
study
was
to
develop
a
prognostic
model
incorporating
glycometabolism
metabolism-related
genes
(GLRGs)
for
accurate
prognosis
assessment
patients
with
endometrial
carcinoma
(EC).